Home Business Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 28%

Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 28%

by admin

Novo Nordisk said Hims & Hers has “failed to adhere to the law which prohibits mass sales of compounded drugs” under the “false guise” of personalization.Original Article

You may also like

Leave a Comment

five × three =